What we do

QMENTA accelerates and improves the chances of successful drug development and clinical care for brain diseases. We designed a cloud-based platform using AI techniques and large amounts of MRI and CT brain images. QMENTA AI Reader is the perfect environment to store, share and analyze multi-site medical imaging data during clinical studies and trials. It allows experts to save time and money in drug development and empowers their objective decision-making based on imaging data insights.

Cost and time efficient imaging workflow

Make sure you concentrate your resources on the most important thing: achieving optimal trial results. We focus on freeing up time and resources for your team, reducing site-burden by up to 75% and getting your imaging costs in the trial down to 50%.*

AI-driven imaging insights for fast & accurate decision-making

Using machine learning and deep neuroimaging knowledge, our FDA cleared algorithms provide automated analysis of large amounts of image data, generating a wide range of biomarkers for the study of the most relevant CNS diseases.

Workflow efficiency and improvement through imaging

Whether patient recruitment, site selection, standardized multi-site data management or drug efficacy measurement over time, we handle the complete imaging part of your trial, from planning and simulating the study to deciding on its efficacy based on imaging data analysis.

Speed up and ease data aggregation and management

Clinical researchers shouldn’t have to spend time and resources on fixing data issues that technology was built to handle. Add large amounts of data from multiple places with just one click and have them automatically anonymized, identified and classified according to your QC standards. Generate statistics and reports to visualize data aggregation and analysis results from anywhere in seconds.

75

Cost savings in imaging collection and storage (1)

75

Cost savings in advanced image analysis (2)

75

Site burden reduction (3)

Data Privacy and Security

All data is safely stored in compliance with HIPAA and Title 21 CFR Part 11. The privacy of patients’ private health information (PHI) is respected at all times with automated de-identification as well as end-to-end encryption.

Cost Savings

Our cloud infrastructure optimizes the total cost of ownership for your IT infrastructure by eliminating the need to heavily invest in computing resources at the beginning of the project and allows you to quickly scale the capacity of your account according to your usage.

Testimonials

QMENTA solutions fill a significant unmet need for all researchers and clinicians working with imaging. In imaging studies from patients with Multiple Sclerosis, their solution for obtaining the brain connectome, quantifying brain damage and relating it with clinical scores is outstanding, and it is going to solve many clinically relevant questions. In addition, I envision QMENTA's solutions are going to be extremely useful in clinical practice and for conducting clinical trials developing new drugs for MS

Pablo Villoslada Diaz, MD, PhDSenior Researcher IDIBAPS; Founder & Scientific Advisor Bionure; Adjunct Professor UCSF

My lab has been working with QMENTA primarily for developing a new treatment for Down syndrome using MRI at pre-clinical validation with mice models. Their platform is necessary to accelerate the discoveries in the field and will have a very large impact. The platform that they provide is a great tool for data management and processing. It is very flexible and efficient, providing quick answers to our research questions. We feel very comfortable and satisfied to work with the team, given their scientific approach that turns their product as a partner, rather than just a tool.

Mara Dierssen, MD, PhDSystems Biology Program at a large center for genomics investigations

This technology changes dramatically the way we understand these diseases, and help us determine which parts of the brain are not working properly. We are using these quantification tools to detect easier which brain regions are damaged and help us find better and personalized treatments for our patients.

Angels García-Cazorla, MD, PhDHospital Sant Joan de Déu

Ready to start?

Register now or contact us.